NeuroDerm Ltd. Ordinary Shares
NDRM
NDRM was delisted on the 17th of October, 2017.
5 hedge funds and large institutions have $1.3M invested in NeuroDerm Ltd. Ordinary Shares in 2017 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 76 closing their positions.
94% less funds holding
Funds holding: 81 → 5 (-76)
99% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 76
100% less capital invested
Capital invested by funds: $501M → $1.3M (-$499M)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FWM
Focused Wealth Management
Newburgh,
New York
|
+$1.25K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$53.3M |
| 2 |
SAM
Sandell Asset Management
New York
|
-$43.9M |
| 3 |
OP
Omni Partners
London,
United Kingdom
|
-$43.4M |
| 4 |
JP Morgan Chase
New York
|
-$28.8M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$22.9M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Morgan Stanley
New York
| – | -$37K | -950 | Closed |
|
|
FPF
77
FNY Partners Fund
New York
| – | -$27K | -700 | Closed |
|
78
Wells Fargo
San Francisco,
California
| – | -$20K | -500 | Closed |
|
79
Legal & General Group
London,
United Kingdom
| – | -$18K | -460 | Closed |
|
|
TRCT
80
Tower Research Capital (TRC)
New York
| – | -$10K | -264 | Closed |
|
NDRM Hedge Fund Activity: Q4 2017 in Review
5 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in NeuroDerm Ltd. Ordinary Shares (NDRM) for Q4 2017, worth a combined $1.3M — down 100% from $501M a quarter earlier.
Sellers outnumbered buyers: 76 funds closed out of NDRM and 1 opened new positions — a net loss of 75 holders — while 1 trimmed existing stakes and 0 added.
The largest buyer was Focused Wealth Management, opening a new position worth an estimated $1.25K. The largest seller was AQR Arbitrage, exiting entirely with an estimated $53.3M sold.
- 5 institutional investors held NeuroDerm Ltd. Ordinary Shares (NDRM) as of Q4 2017, down from 81 in Q3 2017.
- Funds reported $1.3M of NeuroDerm Ltd. Ordinary Shares stock for Q4 2017, down 100% quarter-over-quarter.
- 1 fund opened new NeuroDerm Ltd. Ordinary Shares positions in Q4 2017 and 76 closed out, a net change of -75 holders.
- The largest NeuroDerm Ltd. Ordinary Shares buyer in Q4 2017 was Focused Wealth Management, an estimated $1.25K added.
- The largest NeuroDerm Ltd. Ordinary Shares seller in Q4 2017 was AQR Arbitrage, an estimated $53.3M sold.
Based on aggregated 13F filings for Q4 2017.